Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

State’s venture capital funding declines

Get in Touch

By Scott Meacham

Copyright © 2014, The Oklahoma Publishing Company

Access to capital and robust deal flow are the dual engines of entrepreneurial growth.

According to the PricewaterhouseCoopers LLP/National Venture Capital Association MoneyTree Report, in 2013, the state of Oklahoma ranked 44th in terms of venture capital investment dollars.

What’s really unfortunate is that we are trending in the wrong direction. In 2008, there was $17 million in venture capital invested here; last year it had fallen to $8 million, with the vast majority of that investment being deals in which i2E invested.

While most states seem to have returned to pre-financial crisis levels over that last five years, venture capital investment in Oklahoma declined more than 50 percent.

From 2012 to 2013, as total venture capital investment dollars in the U.S. grew about 7.5 percent, venture capital invested in Oklahoma declined 75 percent. Colorado had 79 deals. We had eight.

Even though the state and angel investors here have worked to create proof-of-concept and seed funding, the lack of venture capital is holding us back, especially when it comes to bio-science opportunities.

Venture capital attracts venture capital, and there isn’t enough VC money here to prime the pump. Venture capitalists are opening offices and writing checks in states around us — notably Texas and Colorado — but only a handful of VCs have been active in Oklahoma at al — and most of those fly in from some other state.

Robust deal flow is the second thing that attracts venture capitalist. In Oklahoma, we need more fundable deals. Our universities and research institutions are outstanding. There is always new technology being invented and developed at places like the University of Oklahoma, Oklahoma State University and the Oklahoma Medical Research Foundation. The problem in Oklahoma seems to not be so much the lack of university/nonprofit innovation but the lack of substantial and ongoing private sector innovation. We have some; just not enough.

We need to look for ways to build on what we have and encourage more entrepreneurial risk taking.

Colorado launched an advanced industries acceleration program that makes $150,000 to $500,000 grants available to support commercialization by key industries for proof-of-concept, early stage capital, and infrastructure.

New York’s 2014 fiscal year budget includes $50 million for a venture capital fund to provide seed and early stage funding for new company formation and to help commercialize new technologies and products.

In Wisconsin, lawmakers passed legislation to create a $75 million early stage seed capital fund to support high growth sectors, with $25 million from the state and the remainder from private sources.

In Oklahoma, we need to redouble our efforts to pull together across academia and the private sector to develop more efficient and faster ways to commercialize innovation into products and services that create jobs. It’s not just more capital. We need more deals.

Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based start-up companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology. Contact Meacham at [email protected]

 

  • admin
    admin

More News

Loading...
Black doctor smiling with stethoscope
Blog, i2E
02.09.23

Titan Intake Automates Patient Referrals to Accelerate Care

Read more
man and woman reviewing paperwork at a table
Blog, i2E, News
01.10.23

Stories of Oklahoma Innovation: Building a Startup

Read more
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E